Anfield Capital Management, LLC Ark Genomic Revolution ETF (De Transaction History
Anfield Capital Management, LLC
- $263 Million
- Q4 2024
A detailed history of Anfield Capital Management, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Anfield Capital Management, LLC holds 301 shares of ARKG stock, worth $6,615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
301
Previous 301
-0.0%
Holding current value
$6,615
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ARKG
# of Institutions
282Shares Held
23.3MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$79.7 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$76.6 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$61.4 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$61.2 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$36.4 Million0.02% of portfolio